aureus (MRSA), and carbapenem-resistant Acinetobacter baumannii
ADJUNCT ONE was a 52-week, double-blind, treat-to-target study conducted in 1398 people randomised 3:1 to receive liraglutide (1.8 mg, 1.2 mg or 0.6 mg) or placebo, in 177 centres in 17 countries (Mathieu et al, 2016)
PubMed , Genome Biology and Evolution , vol
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr
NICE guidance recommends benzodiazepines like alprazolam for short-term use only (24 weeks) due to dependence risks
important for validating cross-species effects Humans Multiple Phase 1-3 trials in healthy volunteers and patients with sexual dysfunction Cell culture MC4R-expressing cell lines for receptor binding and signaling studies Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite FDA approval for a specific indication and extensive research over two decades, PT-141 faces several important limitations that restrict broader clinical application and understanding